Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1028 of 5804
-
Could less radiation be better for prostate cancer?
Symptom relief Recruiting nowThe purpose of this study is to see whether giving a lower (de-escalated) dose of radiation therapy to some parts of the prostate can reduce side effects compared to giving the same (uniform) dose of radiation therapy to the whole prostate.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Caffeine boost may shield preterm Babies' kidneys
Disease control Recruiting nowThis study is being done to see if additional caffeine citrate (20 milligrams per kilogram IV bolus) helps babies with low kidney oxygenation already being treated with caffeine citrate (20 milligrams per kilogram IV bolus on day of life (DOL) 1 followed by 8 milligrams per kilog…
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Smart brace could keep Kids' spines straight without surgery
Disease control Recruiting nowThe goal of this clinical trial is to learn if the RESILIENT Scoliosis Brace System works to treat children with idiopathic scoliosis. It will also learn about the safety, comfort, and usability of the brace. The main questions it aims to answer are: * Can the RESILIENT brace pr…
Phase: NA • Sponsor: Thinks Works, PBC • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug takes aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThe purpose of this study is to find the best dose of the drug and measure the safety and efficacy of LY4152199 in participants with previously treated B-cell malignancies. Participants will have the option to continue taking LY4152199 until the study ends.
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
A simple urine test and a smart alert may help predict kidney failure in sick kids
Disease control Recruiting nowThe goal of this study is to learn whether adding a clinical decision support tool to the electronic medical record helps clinicians use the furosemide stress test in critically ill children at high risk for severe acute kidney injury (AKI). The main question it aims to answer is…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a magnetic helmet help kids with delayed speech?
Symptom relief Recruiting nowThis study explores a safe and effective new approach to improve language function in children with Global Developmental Delay (GDD). Conducted at Xiangxi Autonomous Prefecture People's Hospital, the study will recruit approximately 50 children aged 2 to 5 years. Participants wil…
Phase: NA • Sponsor: Xiangya Hospital of Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Experimental drug targets Low-Oxygen tumors in prostate cancer
Disease control Not yet recruitingThis is a single-institution, single-arm, open-label Phase 2 trial evaluating evofosfamide in subjects with M1 CRPC who fail first-line ARSIs. In those progressing after second-line Docetaxel or deemed ineligible to it, the use of alternate ARSI remains the most common line of th…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could an ancient herb keep breast cancer at bay?
Disease control CompletedAstragalus polysaccharides (APS), acting as an immunomodulator, is known to modulate the tumor microenvironment and inhibit tumor growth and progression, thereby suggesting potential as an adjuvant cancer therapy to improve treatment outcomes. PG2 (APS Injection) has completed a…
Sponsor: Kun-Ming Rau • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat lung cancer
Disease control Recruiting nowThe researchers are doing this study to find out whether the combination of tepotinib and ivonescimab is a safe and effective treatment for people with non-small cell lung cancer (NSCLC) that is positive for METex14 skipping. The researchers will test up to two different doses of…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Carpal tunnel surgery could spot hidden heart disease risk
Diagnosis Recruiting nowTransthyretin amyloidosis (ATTR) is an underdiagnosed condition that can present early as carpal tunnel syndrome, sometimes preceding cardiac involvement by several years. The recent emergence of new treatments underscores the importance of early diagnosis. Synovial biopsy perfor…
Phase: NA • Sponsor: Clinique Saint Jean, France • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New triple therapy aims to wipe out rectal cancer before surgery
Disease control OngoingThis study aims to evaluate the efficacy and safety of neoadjuvant short-course radiotherapy combined with Retlirafusp alfa and CAPOX chemotherapy in the treatment of locally advanced rectal cancer. This is a prospective, single-arm, phase II clinical trial planned to enroll 44 p…
Phase: PHASE2 • Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New HPV vaccine batch trial aims to ensure reliable protection
⭐️ VACCINE ⭐️ Recruiting nowTo support international market access and comply with World Health Organization Prequalification requirements, this lot-to-lot consistency trial is planned for initiation. The goal of this clinical trial is to evaluate lot-to-lot immunogenicity and safety of Recombinant Human Pa…
Phase: PHASE4 • Sponsor: Xiamen Innovax Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:02 UTC
-
Experimental immune therapy aims to reduce deaths in severe pneumonia
Disease control Recruiting nowThis clinical trial will evaluate the efficacy and safety of a single intravenous dose of agenT-797 administered in addition to standard of care (SOC), compared with placebo plus SOC, in reducing short-term mortality in adult participants with severe pneumonia and moderate to sev…
Phase: PHASE2 • Sponsor: MiNK Therapeutics • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New water treatment could slash diarrhea in nigerian villages
Prevention Not yet recruitingThis study evaluates the implementation and effectiveness of in-line chlorination (ILC) for improving drinking water quality in rural Nigeria. Unsafe drinking water remains a major contributor to diarrheal disease, particularly among children under five. Inline chlorination is a …
Phase: NA • Sponsor: University of California, Berkeley • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Sound waves to wake the brain? new study tests ultrasound for consciousness disorders
Knowledge-focused Recruiting nowThe overall aim of this study is to develop an intervention that can help recovery in patients surviving severe brain injury but failing to fully recover. In particular, this project aims to (1) determine neurobehavioral responses to low-intensity focused ultrasound (LIFUP) in pa…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a single CT scan spot lung cancer and other diseases early?
Diagnosis Recruiting nowLung cancer is one of the most common and serious cancers in Scotland and is often diagnosed at a late stage. Early detection is crucial to improving survival rates. The value of screening for lung cancer with low-dose CT (LDCT) scans has been established, and these scans can als…
Phase: NA • Sponsor: NHS Greater Glasgow and Clyde • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Walking rehab gets a boost: High-Intensity therapy tested for spinal cord injury
Symptom relief Recruiting nowPeople with incomplete spinal cord injury (SCI) often have some preserved movement and may regain walking ability, but recovery can be limited, and more effective rehabilitation approaches are needed.The goal of this clinical trial is to learn if high-intensity walking rehabilita…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New nasal spray COVID booster enters human testing
⭐️ VACCINE ⭐️ Recruiting nowThis phase 1 randomized, open-label, dose-escalation clinical trial evaluates the safety and immunogenicity of OCU500, a ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine, in healthy adults aged 18-64 who previously completed a primary COVID-19 vaccination series and at least one b…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 26, 2026 00:00 UTC
-
Can a Cholesterol-Lowering drug stop brain arteries from narrowing further?
Disease control Recruiting nowThe goal of this clinical trial is to learn whether pemafibrate can help prevent worsening of intracranial arterial stenosis (ICAS) in patients who have symptomatic ICAS and high triglycerides (TG) levels after ischemic stroke or transient ischemic attack (TIA). The main questio…
Phase: NA • Sponsor: Tokyo Women's Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain training and new drug combo tested to fight memory loss in stroke risk patients
Disease control Not yet recruitingThis study aims to evaluate whether digital cognitive training and/or intensive lipid-lowering therapy with a PCSK9 inhibitor can improve cognitive function in patients with intracranial atherosclerosis (ICAS). ICAS is a common cause of stroke and is also linked to thinking and …
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC